why choose us

First received: November 12, 2022

Clinical Trial: A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Colorectal Cancer

Study Type: INTERVENTIONAL


Official Title: A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-Alpha Inhibitor, TOS-358, in Adult Subjects With Select Solid Tumors

Brief Summary: The goal of this clinical trial is to evaluate the safety of TOS-358 in adults with select solid tumors who meet study enrollment criteria.The main questions it aims to answer are:what is the maximum tolerated dose and recommended dose for phase 2?how safe and tolerable is TOS-358 at different dose levels when taken orally once or twice per day?

Read more